Parkinson's cell therapy bemdaneprocel shortens off time

A Stem Cell Therapy for Parkinson’s Disease Heads to Phase 3 Trials

Scientists developed new brain cells to replace those lost in Parkinson’s. Early trials showed they’re safe — now, larger human trials are on the... The post A Stem Cell Therapy for Parkinson’s Disease Heads to Phase 3 Trials appeared first on Being Patient.

Patients with Parkinson's disease have regained better mobility, calm sleep and improved quality of life after receiving stem cell transplants directly into the brain. For the first time, clinical trials have shown that these cells can survive, produce dopamine and sustainably mitigate motor symptoms. A medical breakthrough that researchers have been hoping for for for more than two decades. Although conducted on a limited number of patients, th…

Parkinson's cell therapy bemdaneprocel shortens off time

Adults with Parkinson’s disease treated with the cell therapy bemdaneprocel spent less time in off periods, when symptoms were not adequately controlled despite medication use. That’s according to final published data from the exPDite Phase 1 trial (NCT04802733), which also showed that the cell therapy boosted the time with well-controlled symptoms. Bluerock Therapeutics expects to launch a Phase 3 clinical trial, exPDite-2, in the first half of…